Magliano, D. J. & Boyko, E. IDF Diabetes Atlas 10th edn (International Diabetes Federation, 2021).
ElSayed, N. A. et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes — 2023. Diabetes Care 46, S19–S40 (2022).
Google ScholarÂ
Campbell, J. E. & Newgard, C. B. Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat. Rev. Mol. Cell Biol. 22, 142–158 (2021).
Google ScholarÂ
Li, M. et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal. Transduct. Target. Ther. 7, 216 (2022).
Google ScholarÂ
Weir, G. C., Butler, P. C. & Bonner-Weir, S. The β-cell glucose toxicity hypothesis: attractive but difficult to prove. Metabolism 124, 154870 (2021).
Google ScholarÂ
Tomic, D., Shaw, J. E. & Magliano, D. J. The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 18, 525–539 (2022).
Google ScholarÂ
Stern, D. et al. Sugar-sweetened soda consumption increases diabetes risk among Mexican women. J. Nutr. 149, 795–803 (2019).
Google ScholarÂ
den Biggelaar, L. J. C. J. et al. Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study. Eur. J. Nutr. 59, 1717–1727 (2020).
Google ScholarÂ
Silbernagel, G. et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br. J. Nutr. 106, 79–86 (2011).
Google ScholarÂ
Olefsky, J. M. & Reaven, G. M. Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 23, 449–453 (1974).
Google ScholarÂ
Kolterman, O. G., Greenfield, M., Reaven, G. M., Saekow, M. & Olefsky, J. M. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 28, 731–745 (1979).
Google ScholarÂ
Aeberli, I. et al. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men. Diabetes Care 36, 150–156 (2013).
Google ScholarÂ
Harwood, H. J., Listrani, P. & Wagner, J. D. Nonhuman primates and other animal models in diabetes research. J. Diabetes Sci. Technol. 6, 503–514 (2012).
Google ScholarÂ
Yoshioka, M., Kayo, T., Ikeda, T. & Koizuni, A. A novel locus, mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46, 887–894 (1997).
Google ScholarÂ
Heinke, S. et al. Diabetes induction by total pancreatectomy in minipigs with simultaneous splenectomy: a feasible approach for advanced diabetes research. Xenotransplantation 23, 405–413 (2016).
Google ScholarÂ
King, A. J. The use of animal models in diabetes research. Br. J. Pharmacol. 166, 877–894 (2012).
Google ScholarÂ
King, A. & Bowe, J. Animal models for diabetes: understanding the pathogenesis and finding new treatments. Biochem. Pharmacol. 99, 1–10 (2016).
Google ScholarÂ
Masiello, P. Animal models of type 2 diabetes with reduced pancreatic β-cell mass. Int. J. Biochem. Cell Biol. 38, 873–893 (2006).
Google ScholarÂ
Ghasemi, A., Khalifi, S. & Jedi, S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol. Hung. 101, 408–420 (2014).
Google ScholarÂ
Szkudelski, T. Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. 237, 481–490 (2012).
Google ScholarÂ
Radenković, M., Stojanović, M. & Prostran, M. Experimental diabetes induced by alloxan and streptozotocin: the current state of the art. J. Pharmacol. Toxicol. Methods 78, 13–31 (2016).
Google ScholarÂ
Furman, B. L. Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 70, 5.47.1–5.47.20 (2015).
Google ScholarÂ
Sheng, Q. et al. Autophagy protects pancreatic beta cell mass and function in the setting of a high-fat and high-glucose diet. Sci. Rep. 7, 16348 (2017).
Google ScholarÂ
Murase, M. et al. Functional adenosine triphosphate-sensitive potassium channel is required in high-carbohydrate diet-induced increase in β-cell mass. J. Diabetes Investig. 10, 238–250 (2019).
Google ScholarÂ
Rivière, S. et al. High fructose diet inducing diabetes rapidly impacts olfactory epithelium and behavior in mice. Sci. Rep. 6, 34011 (2016).
Google ScholarÂ
Sievenpiper, J. L., Souza, R. J. de, Kendall, C. W. C. & Jenkins, D. J. A. Is fructose a story of mice but not men? J. Am. Diet. Assoc. 111, 219–220 (2011).
Google ScholarÂ
Duh, E. J., Sun, J. K. & Stitt, A. W. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2, e93751 (2017).
Google ScholarÂ
Olivares, A. M. et al. Animal models of diabetic retinopathy. Curr. Diab. Rep. 17, 93 (2017).
Google ScholarÂ
Sergeys, J. et al. Longitudinal in vivo characterization of the streptozotocin-induced diabetic mouse model: focus on early inner retinal responses. Invest. Ophthalmol. Vis. Sci. 60, 807–822 (2019).
Google ScholarÂ
Miloudi, K. et al. NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy. Proc. Natl Acad. Sci. USA 116, 4538–4547 (2019).
Google ScholarÂ
Sohn, E. H. et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc. Natl Acad. Sci. USA 113, E2655–E2664 (2016).
Google ScholarÂ
Zheng, L. et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50, 1987–1996 (2007).
Google ScholarÂ
Samuels, I. S., Bell, B. A., Pereira, A., Saxon, J. & Peachey, N. S. Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes. J. Neurophysiol. 113, 1085–1099 (2015).
Google ScholarÂ
Cubillos, S. & Kazlauskas, A. Manifestation of pathology in animal models of diabetic retinopathy is delayed from the onset of diabetes. Int. J. Mol. Sci. 25, 1610 (2024).
Google ScholarÂ
Kinuthia, U. M., Wolf, A. & Langmann, T. Microglia and inflammatory responses in diabetic retinopathy. Front. Immunol. 11, 564077 (2020).
Google ScholarÂ
Forrester, J. V., Kuffova, L. & Delibegovic, M. The role of inflammation in diabetic retinopathy. Front. Immunol. 11, 583687 (2020).
Google ScholarÂ
Kang, Q. & Yang, C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 37, 101799 (2020).
Google ScholarÂ
Oshitari, T. Advanced glycation end-products and diabetic neuropathy of the retina. Int. J. Mol. Sci. 24, 2927 (2023).
Google ScholarÂ
Geraldes, P. & King, G. L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319–1331 (2010).
Google ScholarÂ
Volpe, C. M. O., Villar-Delfino, P. H., dos Anjos, P. M. F. & Nogueira-Machado, J. A. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 9, 119 (2018).
Google ScholarÂ
Oshitari, T. The pathogenesis and therapeutic approaches of diabetic neuropathy in the retina. Int. J. Mol. Sci. 22, 9050 (2021).
Google ScholarÂ
Rakoczy, E. P. et al. Characterization of a mouse model of hyperglycemia and retinal neovascularization. Am. J. Pathol. 177, 2659–2670 (2010).
Google ScholarÂ
Lai, C.-M. et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol. Ther. 12, 659–668 (2005).
Google ScholarÂ
van Eeden, P. E. et al. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 47, 4638–4645 (2006).
Google ScholarÂ
Gurley, S. B. et al. Impact of genetic background on nephropathy in diabetic mice. Am. J. Physiol. Renal Physiol. 290, F214–F222 (2006).
Google ScholarÂ
Qi, Z. et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54, 2628–2637 (2005).
Google ScholarÂ
Sharma, K., McCue, P. & Dunn, S. R. Diabetic kidney disease in the db/db mouse. Am. J. Physiol. Renal Physiol. 284, F1138–F1144 (2003).
Google ScholarÂ
Couturier, A. et al. Mouse models of diabetes-related ulcers: a systematic review and network meta-analysis. eBioMedicine 98, 104856 (2023).
Google ScholarÂ
Schmidt, R. E. et al. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am. J. Pathol. 163, 2077–2091 (2003).
Google ScholarÂ
Rosso, C. et al. Impact of infarct location on functional outcome following endovascular therapy for stroke. J. Neurol. Neurosurg. Psychiatry 90, 313–319 (2019).
Google ScholarÂ
Bahader, G. A. et al. Type-I diabetes aggravates post-hemorrhagic stroke cognitive impairment by augmenting oxidative stress and neuroinflammation in mice. Neurochem. Int. 149, 105151 (2021).
Google ScholarÂ
Huynh, K. et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free. Radic. Biol. Med. 60, 307–317 (2013).
Google ScholarÂ
Bugger, H. et al. Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57, 2924–2932 (2008).
Google ScholarÂ
Barouch, L. A., Berkowitz, D. E., Harrison, R. W., O’Donnell, C. P. & Hare, J. M. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108, 754–759 (2003).
Google ScholarÂ
Semeniuk, L. M., Kryski, A. J. & Severson, D. L. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 283, H976–H982 (2002).
Google ScholarÂ
Smith, C. C. T. et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br. J. Pharmacol. 149, 5–13 (2006).
Google ScholarÂ
Hodgin, J. B. et al. Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 62, 299–308 (2012).
Google ScholarÂ
Lezoualc’h, F. et al. Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality. Cardiovasc. Res. 119, 1130–1145 (2023).
Google ScholarÂ
Lu, X. et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal. Transduct. Target. Ther. 9, 262 (2024).
Google ScholarÂ
Scarr, D. et al. Ketone production and excretion even during mild hyperglycemia and the impact of sodium-glucose co-transporter inhibition in type 1 diabetes. Diabetes Res. Clin. Pract. 207, 111031 (2024).
Google ScholarÂ
Rebelato, E., Santos, L. R., Carpinelli, A. R., Rorsman, P. & Abdulkader, F. Short-term high glucose culture potentiates pancreatic beta cell function. Sci. Rep. 8, 13061 (2018).
Google ScholarÂ
Liu, Y. Q., Moibi, J. A. & Leahy, J. L. Chronic high glucose lowers pyruvate dehydrogenase activity in islets through enhanced production of long chain acyl-CoA: prevention of impaired glucose oxidation by enhanced pyruvate recycling through the malate-pyruvate shuttle. J. Biol. Chem. 279, 7470–7475 (2004).
Google ScholarÂ
Haythorne, E. et al. Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells. Nat. Commun. 13, 6754 (2022).
Google ScholarÂ
Cheruiyot, A. et al. Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion. J. Clin. Invest. 134, e173280 (2024).
Google ScholarÂ
Ritzel, R. A., Hansen, J. B., Veldhuis, J. D. & Butler, P. C. Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. J. Clin. Endocrinol. Metab. 89, 795–805 (2004).
Google ScholarÂ
Eizirik, D. L., Korbutt, G. S. & Hellerström, C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J. Clin. Invest. 90, 1263–1268 (1992).
Google ScholarÂ
Marshak, S. et al. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48, 1230–1236 (1999).
Google ScholarÂ
Miyazaki, J.-I. et al. Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126–132 (1990).
Google ScholarÂ
Hohmeier, H. E. et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49, 424–430 (2000).
Google ScholarÂ
Scharfmann, R. et al. Development of a conditionally immortalized human pancreatic β cell line. J. Clin. Invest. 124, 2087–2098 (2014).
Google ScholarÂ
Blanchi, B. et al. EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol. Metab. 76, 101772 (2023).
Google ScholarÂ
Muller, Y. L., Wiedrich, K., Sutherland, J., Jones, D. & Baier, L. Assessing gene expression profile and insulin secretion in human beta cells (EndoC-BH3) under glucose exposure [abstract]. Diabetes 72, 1764-P (2023).
Google ScholarÂ
Furuichi, Y. et al. Excess glucose impedes the proliferation of skeletal muscle satellite cells under adherent culture conditions. Front. Cell Dev. Biol. 9, 640399 (2021).
Google ScholarÂ
Aas, V., Kase, E. T., Solberg, R., Jensen, J. & Rustan, A. C. Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 47, 1452–1461 (2004).
Google ScholarÂ
Badu-Mensah, A., Valinski, P., Parsaud, H., Hickman, J. J. & Guo, X. Hyperglycemia negatively affects IPSC-derived myoblast proliferation and skeletal muscle regeneration and function. Cells 11, 3674 (2022).
Google ScholarÂ
Nelson, B. A., Robinson, K. A. & Buse, M. G. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 49, 981–991 (2000).
Google ScholarÂ
Han, C. Y. et al. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56, 2260–2273 (2007).
Google ScholarÂ
Lustig, M., Gefen, A. & Benayahu, D. Adipogenesis and lipid production in adipocytes subjected to sustained tensile deformations and elevated glucose concentration: a living cell-scale model system of diabesity. Biomech. Model. Mechanobiol. 17, 903–913 (2018).
Google ScholarÂ
Shao, J., Qiao, L., Janssen, R. C., Pagliassotti, M. & Friedman, J. E. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 54, 976–984 (2005).
Google ScholarÂ
Shiroyama, K., Moriwaki, K., Kusunoki, S., Saeki, N. & Yuge, O. Glucose loading during primary culture has opposite effects on the viability of hepatocytes exposed to potassium cyanide and to iodoacetic acid. Metab. Clin. Exp. 50, 342–348 (2001).
Google ScholarÂ
Zong, H. et al. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 53, 2656–2666 (2010).
Google ScholarÂ
Saker, S., Stewart, E. A., Browning, A. C., Allen, C. L. & Amoaku, W. M. The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells. Exp. Eye Res. 121, 161–167 (2014).
Google ScholarÂ
Nazeer, A. A. et al. Normal glucose enhances neuronal regeneration after lidocaine-induced injury. Br. J. Anaesth. 104, 482–486 (2010).
Google ScholarÂ
Chung, H.-H. The dysregulation of high glucose-induced iPSC-neural stem cells differentiation by caspase-1. Neurosci. Lett. 865, 138347 (2025).
Google ScholarÂ
Chae, C. W. et al. High glucose-mediated VPS26a down-regulation dysregulates neuronal amyloid precursor protein processing and tau phosphorylation. Br. J. Pharmacol. 179, 3934–3950 (2022).
Google ScholarÂ
Hauguel-de-Mouzon, S., Mrejen, C., Alengrin, F. & Van Obberghen, E. Glucose-induced stimulation of human insulin-receptor mRNA and tyrosine kinase activity in cultured cells. Biochem. J. 305, 119–124 (1995).
Google ScholarÂ
Li, W. et al. Hyperglycemia alters astrocyte metabolism and inhibits astrocyte proliferation. Aging Dis. 9, 674–684 (2018).
Google ScholarÂ
Muona, P., Peltonen, J., Jaakkola, S. & Uitto, J. Increased matrix gene expression by glucose in rat neural connective tissue cells in culture. Diabetes 40, 605–611 (1991).
Google ScholarÂ
Almhanna, K., Wilkins, P. L., Bavis, J. R., Harwalkar, S. & Berti-Mattera, L. N. Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann cells. Neurochem. Res. 27, 1341–1347 (2002).
Google ScholarÂ
Han, H. J., Lee, Y. J., Park, S. H., Lee, J. H. & Taub, M. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 288, F988–F996 (2005).
Google ScholarÂ
Wei, P. Z. et al. Metabolomic changes of human proximal tubular cell line in high glucose environment. Sci. Rep. 9, 16617 (2019).
Google ScholarÂ
Jones, S. C., Saunders, H. J. & Pollock, C. A. High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells. Diabet. Med. 16, 932–938 (1999).
Google ScholarÂ
De Nigris, V. et al. Short-term high glucose exposure impairs insulin signaling in endothelial cells. Cardiovasc. Diabetol. 14, 114 (2015).
Google ScholarÂ
Manea, A. et al. High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ. Cell Tissue Res. 361, 593–604 (2015).
Google ScholarÂ
Irshad, Z. et al. Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal. Sci. Rep. 9, 7889 (2019).
Google ScholarÂ
Mordel, P., Fontaine, F., Dupas, Q., Joubert, M. & Allouche, S. Glucose fluctuation promotes mitochondrial dysfunctions in the cardiomyocyte cell line HL-1. PLoS ONE 18, e0289475 (2023).
Google ScholarÂ
Yeshao, W., Gu, J., Peng, X., Nairn, A. C. & Nadler, J. L. Elevated glucose activates protein synthesis in cultured cardiac myocytes. Metab. Clin. Exp. 54, 1453–1460 (2005).
Google ScholarÂ
Canfield, S. G. et al. High glucose attenuates anesthetic cardioprotection in stem-cell-derived cardiomyocytes: the role of reactive oxygen species and mitochondrial fission. Anesth. Analg. 122, 1269–1279 (2016).
Google ScholarÂ
Wang, M., Zhang, W., Zhu, J., Fu, G. & Zhou, B. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Acta Pharmacol. Sin. 30, 1081–1091 (2009).
Google ScholarÂ
Molgat, A. S. D. et al. Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity. Circulation 130, S70–S76 (2014).
Google ScholarÂ
Wei, F., Zhang, Y., Wang, X. & Huo, J. Effects of high glucose and insulin on the electrophysiological properties of cardiomyocytes derived from human-induced pluripotent stem cells [Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 47, 610–618 (2022).
Google ScholarÂ
Tsai, H.-H. et al. Empagliflozin reduces high glucose-induced cardiomyopathy in hiPSC-derived cardiomyocytes. Stem Cell Rev. Rep. 21, 849–858 (2025).
Google ScholarÂ
Beydag-Tasöz, B. S., Yennek, S. & Grapin-Botton, A. Towards a better understanding of diabetes mellitus using organoid models. Nat. Rev. Endocrinol. 19, 232–248 (2023).
Google ScholarÂ
McVicar, C. M. et al. Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. Diabetologia 58, 1129–1137 (2015).
Google ScholarÂ
Du, Y. et al. Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability. FASEB J. 29, 2194–2204 (2015).
Google ScholarÂ
Bogdanov, P. et al. The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration. PLoS ONE 9, e97302 (2014).
Google ScholarÂ
